(CYTK) - Analyzing Cytokinetics's Short Interest

Cytokinetics's (NYSE:CYTK) short percent of float has fallen 11.8% since its last report. The company recently reported that it has 13.23 million shares sold short, which is 20.7% of all regular share

Benzinga00:00

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Molina Healthcare (MOH) and Cytokinetics (CYTK)

TipRanksApr 30 15:11

Unusual Options Activity: STE, VST and Others Attract Market Bets, STE V/OI Ratio Reaches 107.7

EST Apr 29th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trend

Futu NewsApr 30 04:30

Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress

SOUTH SAN FRANCISCO, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced it will host an investor event and conference call on May 13, 2024 at 4:00 PM Western European

GlobeNewswireApr 30 04:00

Cytokinetics Appoints Sung H. Lee as New CFO

TipRanksApr 27 04:25

On April 23, Cytokinetics Entered Employment Offer Letter With Sung H. Lee, Pursuant To Which, Lee Agreed To Serve As Executive Vice President, CFO

On April 23, Cytokinetics Entered Employment Offer Letter With Sung H. Lee, Pursuant To Which, Lee Agreed To Serve As Executive Vice President, CFO

BenzingaApr 27 04:08